Wednesday, September 12, 2007

Congratulations AstraZeneca UK!



For the number of upheld complaints to the PMCPA recorded for a single promotional item; 27 in all:


• Three breaches of Clause 2 (for bringing the industry into disrepute)

• Five breaches of Clause 9.1 (for not maintaining high standards)

• Five breaches of Clause 10.1 (for conducting disguised promotion)

• One breach of Clause 7.10 (for failing to encourage the rationale use of a medicine)

• Three breaches of Clause 4.1 (for not including prescribing information in the insert)

• Eight breaches of Clauses 7.2 (for making various misleading claims)

• Two breaches of Clause 7.4 (for making claims that were not capable of substantiation).
Is this a record, we ask?

Read all about it here.

3 comments:

InformaticsMD said...

They must have performed their research like this.

Anonymous said...

There are more protections for an industry journals ethics (oooh oxymoron) than there are for patients using statins. When injured by these drugs, and they will be, the consumers bear all the risk. All.

Anonymous said...

Dear Blog Owner

Can you kill the map and videos? They make the site a *^%! to load and might just mean it's too much trouble to bother.

And that would be a shame.